Data confirm the effectiveness and safety of dolutegravir and raltegravir for infants, children, and adolescents living with HIV, but researchers say that long-term monitoring is needed.
A single oral dose of acoziborole proved effective for human African trypanosomiasis in a clinical trial. The drug has potential to greatly simplify and expand treatment for sleeping sickness.
Progress has occurred in reducing maternal-to-child transmission of hepatitis B, a leading cause of liver cancer, but is lagging, particularly in Africa.